Cargando…
Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
BACKGROUND: Roles of cancer stem cells and early growth response gene 1 (Egr1) in carcinogenesis have been extensively studied in lung cancer. However, the role of Egr1 in the metastasis of lung cancer remains undetermined, especially in regard to stem cell-related pathways. METHODS: Egr1, osteopont...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688208/ https://www.ncbi.nlm.nih.gov/pubmed/31399076 http://dx.doi.org/10.1186/s12885-019-6014-5 |
_version_ | 1783442838123446272 |
---|---|
author | Feng, Yin-Hsun Su, Yu-Chu Lin, Shuo-Fu Lin, Pey-Ru Wu, Chao-Liang Tung, Chao-Ling Li, Chien-Feng Shieh, Gia-Shing Shiau, Ai-Li |
author_facet | Feng, Yin-Hsun Su, Yu-Chu Lin, Shuo-Fu Lin, Pey-Ru Wu, Chao-Liang Tung, Chao-Ling Li, Chien-Feng Shieh, Gia-Shing Shiau, Ai-Li |
author_sort | Feng, Yin-Hsun |
collection | PubMed |
description | BACKGROUND: Roles of cancer stem cells and early growth response gene 1 (Egr1) in carcinogenesis have been extensively studied in lung cancer. However, the role of Egr1 in the metastasis of lung cancer remains undetermined, especially in regard to stem cell-related pathways. METHODS: Egr1, osteopontin (OPN) and Oct4 expression in human lung cancer was determined by performing immunohistochemistry. Immunoblotting, ELISA, luciferase reporter assay, chromatin immunoprecipitation assay and RT-PCR were performed to validate the regulation of Oct4-Egr1-OPN axis. Moreover, the effect of Oct4-Egr1-OPN axis on lung cancer progression was evaluated by cell migration assay and mice study. RESULTS: We detected Oct4, Egr1, and OPN expression in clinical specimens from 79 lung cancer patients, including 72 adenocarcinomas and 7 squamous cell carcinomas. High expression of Oct4, Egr1, and OPN accounted for 53, 51, and 57% of the patients, respectively. All of the three biomarkers were positively correlated in clinical human lung cancer. Patients with high expression of OPN were significantly associated with shorter disease-free survivals than those with low expression of OPN (p < 0.05). In lung cancer cells, Oct4 transactivated the Egr1 promoter and upregulated Egr1 expression. In a human lung cancer xenograft model, Oct4-overexpressing tumors expressed elevated levels of Egr1. Furthermore, overexpression of Oct4 in lung cancer cells increased the metastatic potential. CONCLUSIONS: Egr1 exerts a promoting effect on cancer metastasis in Oct4-overexpressing lung cancer. Thus, therapeutic strategies targeting the Oct4/Egr1/OPN axis may be further explored for the treatment of lung cancer, especially when lung cancer is refractory to conventional treatment due to cancer stem cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-6014-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6688208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66882082019-08-14 Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer Feng, Yin-Hsun Su, Yu-Chu Lin, Shuo-Fu Lin, Pey-Ru Wu, Chao-Liang Tung, Chao-Ling Li, Chien-Feng Shieh, Gia-Shing Shiau, Ai-Li BMC Cancer Research Article BACKGROUND: Roles of cancer stem cells and early growth response gene 1 (Egr1) in carcinogenesis have been extensively studied in lung cancer. However, the role of Egr1 in the metastasis of lung cancer remains undetermined, especially in regard to stem cell-related pathways. METHODS: Egr1, osteopontin (OPN) and Oct4 expression in human lung cancer was determined by performing immunohistochemistry. Immunoblotting, ELISA, luciferase reporter assay, chromatin immunoprecipitation assay and RT-PCR were performed to validate the regulation of Oct4-Egr1-OPN axis. Moreover, the effect of Oct4-Egr1-OPN axis on lung cancer progression was evaluated by cell migration assay and mice study. RESULTS: We detected Oct4, Egr1, and OPN expression in clinical specimens from 79 lung cancer patients, including 72 adenocarcinomas and 7 squamous cell carcinomas. High expression of Oct4, Egr1, and OPN accounted for 53, 51, and 57% of the patients, respectively. All of the three biomarkers were positively correlated in clinical human lung cancer. Patients with high expression of OPN were significantly associated with shorter disease-free survivals than those with low expression of OPN (p < 0.05). In lung cancer cells, Oct4 transactivated the Egr1 promoter and upregulated Egr1 expression. In a human lung cancer xenograft model, Oct4-overexpressing tumors expressed elevated levels of Egr1. Furthermore, overexpression of Oct4 in lung cancer cells increased the metastatic potential. CONCLUSIONS: Egr1 exerts a promoting effect on cancer metastasis in Oct4-overexpressing lung cancer. Thus, therapeutic strategies targeting the Oct4/Egr1/OPN axis may be further explored for the treatment of lung cancer, especially when lung cancer is refractory to conventional treatment due to cancer stem cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-6014-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-09 /pmc/articles/PMC6688208/ /pubmed/31399076 http://dx.doi.org/10.1186/s12885-019-6014-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Feng, Yin-Hsun Su, Yu-Chu Lin, Shuo-Fu Lin, Pey-Ru Wu, Chao-Liang Tung, Chao-Ling Li, Chien-Feng Shieh, Gia-Shing Shiau, Ai-Li Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer |
title | Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer |
title_full | Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer |
title_fullStr | Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer |
title_full_unstemmed | Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer |
title_short | Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer |
title_sort | oct4 upregulates osteopontin via egr1 and is associated with poor outcome in human lung cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688208/ https://www.ncbi.nlm.nih.gov/pubmed/31399076 http://dx.doi.org/10.1186/s12885-019-6014-5 |
work_keys_str_mv | AT fengyinhsun oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer AT suyuchu oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer AT linshuofu oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer AT linpeyru oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer AT wuchaoliang oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer AT tungchaoling oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer AT lichienfeng oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer AT shiehgiashing oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer AT shiauaili oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer |